iRay Technology Hits Day High with 4.38% Surge, Outperforming Market

iRay Technology Co., a prominent player in the Pharmaceuticals & Biotechnology sector, has shown significant activity today, gaining 4.38% on October 24, 2025. The stock reached an intraday high of CNY 120.28, reflecting its strong performance relative to the broader market.
Over the past year, iRay Technology has outperformed the China Shanghai Composite, generating a return of 43.64% compared to the index's 20.43%. The company's year-to-date performance stands at an impressive 75.79%, further highlighting its robust market position.

Despite recent gains, the company has faced challenges, including a decline in profits by 27.8% over the past year, even as net sales have grown at an annual rate of 20.57% over the last five years. The stock's price-to-earnings ratio is currently at 48.00, indicating a high valuation relative to its earnings. Additionally, the company maintains a dividend yield of 0.64%, appealing to income-focused investors.

Overall, iRay Technology Co. continues to navigate a complex financial landscape while demonstrating notable short-term gains.